Epidemiology of chronic hepatitis and cirrhosis in Turkey

More documents

Recommendations

Info

SUMMARYHBsAg Prevalence in Turkey: 4,29 %Westturkey: 3,54 %Centralturkey: 4,55 %Eastturkey: 6,88 %Number of HBsAg Positives:71.517.100 x 4,29 % = 3.068.083If 10 % were to have active chronic hepatitis = 306.808patientsPatienten under Therapy: 30.000**SGK – According to net sold pill tablets in Turkey 02/2008 – 02/ 2009
Construction method of the patient cohortLiterature,population data,HBsAg prevelanceAUMS/TYİH patient cohort (n=1323)Age, ALT, HBVDNA, eAgCHB(%) and Cirrhosis (%) (n=330)Age specific HBsAgprevelance (%)Prevalence of cirrh.and non-cirrh. CHBLiterature, Cirrhosis RateAbbreviations: AUMS, Ankara University Medical School;TYIH: Turkey Yüksek İhtisas Hospital
Page 1 and 2: Epidemiology of chronic hepatitis a
Page 3 and 4: Characteristic phases of CHB infect
Page 5 and 6: ETIOLOGY OF HEPATOCELLULAR CARCINOM
Page 7 and 8: FULMINANT HEPATITIS IN TURKEYVIRAL
Page 9 and 10: Chronic Viral Hepatitis in the WEST
Page 11 and 12: Liver Cirrhosis in the WEST: Change
Page 13 and 14: Prevalence of delta hepatitis accor
Page 15 and 16: Change in delta hepatitis prevalenc
Page 17 and 18: MethodsEstablishing the patient coh
Page 19 and 20: Mathematic ModelMarkov SimulationSp
Page 21 and 22: Reults of a 20 year projection:Natu
Page 23: Liver-specific death rate in the CH
Page 27: Greetings from ISTANBUL

Epidemiology of chronic hepatitis and cirrhosis in Turkey

Create successful ePaper yourself

Delete template?

Save as template?